MedPath

Added Value of inReach Software on Performance Characteristics of Standard Bronchoscopy

Not Applicable
Completed
Conditions
Lung Disease
Registration Number
NCT00817167
Lead Sponsor
superDimension Ltd.
Brief Summary

The study is aimed to evaluate and describe the added value of inReach planning software on performance characteristics of standard bronchoscopy.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Candidates for non-emergency bronchoscopy
  • Must provide signed informed consent
  • Male or female above 18 years old
  • Lung lesions up to 3 cm in size (in largest diameter), non-visible by standard bronchoscope
Exclusion Criteria
  • CT done over a month before the bronchoscopy procedure

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Bronchoscopy Diagnostic Yield, compared between two study groups and calculated as percentage of true diagnoses from total number of bronchoscopy procedures.Until the definitive diagnosis is obtained
Secondary Outcome Measures
NameTimeMethod
Bronchoscopy Safety Profile, compared between two groups and calculated as percentage of bronchoscopy-related adverse events.At discharge from bronchoscopy unit

Trial Locations

Locations (1)

Pulmonology Department, Tel Aviv Sourasky Medical Center

🇮🇱

Tel Aviv, Israel

Pulmonology Department, Tel Aviv Sourasky Medical Center
🇮🇱Tel Aviv, Israel

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.